MB
Mohammad Saleem
Polycomb Scientific Solutions and Logistics, Labcorp Drug Development, Rush University Rush Medical College
0000-0002-7422-7967
Employment
-
Polycomb Scientific Solutions and Logistics Chief Scientific Officer2025 - Present
-
Labcorp Drug Development Study Director2023 - 2025
-
Rush University Rush Medical College Vice Chair / Professor2021 - 2022
-
Regents of the University of Minnesota Professor2010 - 2021
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (71)
- Integrating transcriptomics with disease-gene network and identification of EGFR kinase target: inhibitor discovery through virtual screening of natural compounds for brain cancer therapy. Save
- Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase. Save
- Refining Colorectal Cancer Classification and Clinical Stratification Through a Single-Cell Atlas Save
- Refining colorectal cancer classification and clinical stratification through a single-cell atlas Save
- Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor Save
- Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition Save
- A novel terpenoid class for prevention and treatment of KRAS‐driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems Save
- Receptor tyrosine kinase (c-Kit) inhibitors: A potential therapeutic target in cancer cells Save
- PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts Save
- Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer Save